The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Phase 3, Open-label, Crossover Study to Evaluate Self-administration of Rozanolixizumab by Study Participants With Generalized Myasthenia Gravis (gMG)
Official Title: An Open-label, Crossover Study to Evaluate Rozanolixizumab Self-administration by Study Participants With Generalized Myasthenia Gravis
Study ID: NCT05681715
Brief Summary: The purpose of this study is to evaluate the ability of study participants with generalized Myasthenia Gravis (gMG) to successfully self-administer rozanolixizumab after training in the self-administration technique using the syringe driver and manual push methods.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Mg0020 50092, Orange, California, United States
Mg0020 50099, San Francisco, California, United States
Mg0020 50561, Lexington, Kentucky, United States
Mg0020 50090, Winston-Salem, North Carolina, United States
Mg0020 50560, Edmonton, , Canada
Mg0020 50069, Toronto, , Canada
Mg0020 20161, Tbilisi, , Georgia
Mg0020 20165, Tbilisi, , Georgia
Mg0020 20305, Tbilisi, , Georgia
Mg0020 40140, Göttingen, , Germany
Mg0020 40177, Münster, , Germany
Mg0020 40144, Milano, , Italy
Mg0020 40146, Pavia, , Italy
Mg0020 40150, Roma, , Italy
Mg0020 20068, Chiba-shi, , Japan
Mg0020 20078, Hanamaki-shi, , Japan
Mg0020 20077, Sendai, , Japan
Mg0020 20076, Shinjuku-ku, , Japan
Mg0020 40155, Gdansk, , Poland
Mg0020 40727, Lodz, , Poland
Mg0020 40153, Poznan, , Poland
Mg0020 40729, NIS, , Serbia
Mg0020 40160, Barcelona, , Spain
Mg0020 40267, Barcelona, , Spain
Mg0020 40308, San Sebastián de Los Reyes, , Spain
Mg0020 40168, Nottingham, , United Kingdom
Mg0020 40163, Oxford, , United Kingdom
Name: UCB Cares
Affiliation: 001 844 599 2273
Role: STUDY_DIRECTOR